Literature DB >> 13824151

Controlled double-blind trial of "persantin" in treatment of angina pectoris.

T FOULDS, J MACKINNON.   

Abstract

Entities:  

Keywords:  ANGINA PECTORIS/therapy; VASODILATOR AGENTS/therapy

Mesh:

Substances:

Year:  1960        PMID: 13824151      PMCID: PMC2097793          DOI: 10.1136/bmj.2.5202.835

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  [Persantin, a new substance for therapy of coronary insufficiency].

Authors:  P JUNEMANN
Journal:  Munch Med Wochenschr       Date:  1959-02-20

2.  [Pharmacological properties of a new coronary dilator substance 2, 6-bis(diethanolamino)-4, 8-dipiperidino-pyrimido[5,4-d]pyrimidine].

Authors:  R KADATZ
Journal:  Arzneimittelforschung       Date:  1959-01

3.  [Effect of a pyrimido-pyrimidine derivative on the oxygen supply of the heart muscle].

Authors:  H J BRETSCHNEIDER; A FRANK; U BERNARD; K KOCHSIEK; F SCHELER
Journal:  Arzneimittelforschung       Date:  1959-01
  3 in total
  7 in total

1.  To-day's Drugs.

Authors: 
Journal:  Br Med J       Date:  1963-07-13

2.  The dark side of the moon of coronary vasodilation.

Authors:  Raffaele Giubbini; Francesco Bertagna
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07       Impact factor: 9.236

Review 3.  Do we still need dipyridamole?

Authors:  C R Gibbs; G Y Lip
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

4.  Controlled trial of dipyridamole in cerebral vascular disease.

Authors:  J Acheson; G Danta; E C Hutchinson
Journal:  Br Med J       Date:  1969-03-08

5.  Haemodynamic effects of dipyridamole at rest and during exercise in healthy subjects.

Authors:  G A Bousvaros; J E Campbell; M McGregor
Journal:  Br Heart J       Date:  1966-05

6.  Antiplatelet agents in coronary disease: are they of prophylactic value?

Authors:  M Verstraete
Journal:  Drugs       Date:  1978-06       Impact factor: 9.546

7.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.